Public Pricelist
  1. All Products
  2. VWR / Merck Chemicals
  3. BMS-303141 is a potent inhibitor of ATP citrate lyase (ACL) (IC₅₀ = 0.13 µM for human recombinant ACL). BMS-303141 inhibits lipid s ynthesis in HepG2 cells with an IC₅₀ of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model

BMS-303141 is a potent inhibitor of ATP citrate lyase (ACL) (IC₅₀ = 0.13 µM for human recombinant ACL). BMS-303141 inhibits lipid s ynthesis in HepG2 cells with an IC₅₀ of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model

Item Number: BIOV2821-50
Unit of Measure: 50 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923611/image_1920?unique=615cf7b

738.00 CHF 738.0 CHF 738.00 CHF

738.00 CHF

Not Available For Sale

    This combination does not exist.

    Current delivery time on request
    Contact Us
    Manufacturer: BIOVISION
    Manufacturer Number: 2821-50
    Storage Temperature: Freezer (-20)

    BMS-303141 is a potent inhibitor of ATP citrate lyase (ACL) (IC₅₀ = 0.13 µM for human recombinant ACL). BMS-303141 inhibits lipid s ynthesis in HepG2 cells with an IC₅₀ of 8 μM, and lowers plasma triglycerides in a murine hyperlipdemia model